Vol 7, No 5 (2012): Supplement - Abstracts
In vitro evaluation of nanoliposomal doxorubicin modified with tat peptide developed by post-insertion method on C-26 colon carcinoma cell line AbstractPDF
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
